Form 4: Alumis Inc. Chief Scientific Officer Reports Changes in Beneficial Ownership
SEC Form 4
David M. Goldstein, Chief Scientific Officer of Alumis Inc., reports transactions involving Class A Common Stock and stock options, including reclassification of shares and vesting schedules.
Summary
- On July 1, 2024, David M. Goldstein, the Chief Scientific Officer of Alumis Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
- The transactions involve the reclassification of Class A Common Stock into voting Common Stock, as well as the acquisition and disposal of stock options.
- The reclassification was exempt under Rule 16b-7 and Rule 16b-3, with each share of Class A Common Stock converted into one share of voting Common Stock.
- Goldstein's transactions included the acquisition and disposal of 42,780, 171,122, 11,978, 30,642, 206,074 and 53,475 stock options at an exercise price of $8.84, $10.2 and $13.33 respectively.
- These options have various vesting schedules, with portions vesting on specific dates and the remainder vesting in monthly installments, contingent on continuous service to Alumis Inc.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing, so the sentiment is neutral. It reflects standard insider transactions and vesting schedules.
Positives
- The reclassification of shares simplifies the capital structure of Alumis Inc.
- The vesting schedules of the stock options incentivize continued service and potentially align the executive's interests with the company's long-term performance.
Risks
- The vesting of certain stock options is contingent on the Issuer's satisfaction of certain performance criteria, which may not be met.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing is specific to Alumis Inc. and doesn't provide broader industry context.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Share Reclassification | Each share of Class A Common Stock was reclassified into one share of voting Common Stock. | 2024-07-01 | Simplifies the company's capital structure. |
Stakeholder Impact
- Shareholders may be interested in the insider transactions as an indicator of management's confidence in the company.
- Employees holding stock options are directly impacted by the vesting schedules outlined in the report.
Key Dates
| Date | Description |
|---|---|
| 2014-03-04 | Date of the Baily Goldstein Living Trust. |
| 2023-01-27 | Initial vesting date for some stock options. |
| 2024-01-27 | Vesting date for some stock options. |
| 2024-05-06 | Performance criteria date for some stock options. |
| 2024-05-22 | Initial vesting date for some stock options. |
| 2024-06-05 | Vesting date for some stock options. |
| 2024-06-06 | Initial vesting date for some stock options. |
| 2024-07-01 | Date of the reported transactions. |
| 2024-07-03 | Date of the report filing. |
| 2024-10-08 | Vesting date for some stock options. |
| 2024-10-09 | Initial vesting date for some stock options. |
| 2025-06-06 | Initial vesting date for some stock options. |
| 2028-05-06 | Performance criteria date for some stock options. |
| 2029-05-06 | Performance criteria date for some stock options. |
| 2030-05-06 | Performance criteria date for some stock options. |
| 2032-01-26 | Expiration date for some stock options. |
| 2033-06-22 | Expiration date for some stock options. |
| 2033-10-08 | Expiration date for some stock options. |
| 2034-05-05 | Expiration date for some stock options. |
| 2034-06-05 | Expiration date for some stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.